Abstract:Background: Bis-chalcone compounds with symmetrical structures, either isolated from natural products or chemically synthesized, have multiple pharmacological activities. Asymmetric Bis-chalcone compounds have not been reported before, which might be attributed to the synthetic challenges involved, and it remains unknown whether these compounds possess any potential pharmacological activities. Aims: The aim of this study is to investigate the synthesis route of asymmetric bis-chalcone compounds and identify potential candidates with efficient anti-tumor activity. Methods: The two-step structural optimization of the bis-chalcone compounds was carried out sequentially, guided by the screening of the compounds for their growth inhibitory activity against gastric cancer cells by MTT assay. The QSAR model of compounds was established through random forest (RF) algorithm. The activities of the optimal compound J3 on growth inhibition, apoptosis, and apoptosis-inducing protein expression in gastric cancer cells were investigated sequentially by colony formation assay, flow cytometry, and western blotting. Further, the inhibitory effects of J3 on the FGFR1 signaling pathway were explored by Western Blotting, shRNA, and MTT assays. Finally, the in vivo anti-tumor activity and mechanism of J3 were studied through nude mice xenograft assay, western blotting. Results: 27 asymmetric bis-chalcone compounds, including two types (N and J) were sequentially designed and synthesized. Some N-class compounds have good inhibitory activity on the growth of gastric cancer cells. The vast majority of J-class compounds optimized on the basis of N3 exhibit excellent inhibitory activity on gastric cancer cell growth. We established a QSAR model (R2 = 0.851627) by applying random forest algorithms. The optimal compound J3, which had better activity, concentration-dependently inhibited the formation of gastric cancer cell colonies and led to cell apoptosis by inducing the expression of the pro-apoptotic protein cleaved PARP in a dose-dependent manner. J3 may exert anti-gastric cancer effects by inhibiting the activation of FGFR1/ERK pathway. Moreover, at a dose of 10 mg/kg/day, J3 inhibited tumor growth in nude mice by nearly 70% in vivo with no significant toxic effect on body weight and organs. Conclusion: In summary, this study outlines a viable method for the synthesis of novel asymmetric bischalcone compounds. Furthermore, the compound J3 demonstrates substantial promise as a potential candidate for an anti-tumor drug.

Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2

Anticancer property of ginsenoside Rh2 from ginseng

Synthesis and Anti-Cancer Activity Studies of Dammarane-Type Triterpenoid Derivatives

Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications

Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review

Preparation And Inhibitory Effects Of 20(S)-Ginsenoside Rh-2 On Hep-A-22 Cells

Ginsengenin derivatives synthesized from 20(R)-panaxotriol: Synthesis, characterization, and antitumor activity targeting HIF-1 pathway

Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion

Structural Modification of Ginsenoside Rh-2 by Fatty Acid Esterification and Its Detoxification Property in Antitumor

Semisynthesis and bioactive evaluation of oxidized products from 20(S)-ginsenoside Rg3, Rh2, protopanaxadiol (PPD) and their 20(R)-epimers as cytotoxic agents

Synthesis of Δ20-Ginsenosides Rh4, (20E)-Rh3, Rg6 and Rk1: A General Approach to Access Dehydrated Ginsenosides.

Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2

Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds

Biosynthesis of Plant-Derived Ginsenoside Rh2 in Yeast Via Repurposing a Key Promiscuous Microbial Enzyme

Ginsenoside - a promising natural active ingredient with steroidal hormone activity

Esterified Derivatives of Panaxadiol and Their Inhibitory Effect on HL‐60, THP‐1, and PC‐3 Cell Lines

A Novel Derivative of Ginsenoside Sapogenin and Its Activity Against HL-60 Cells

Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action

Total Synthesis of Dammarane-Type Saponins Ginsenoside Re and Notoginsenoside R1

Ginsenosides As Anticancer Agents: in Vitro and in Vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action